Brain-shuttle biologics chart new paths across the blood–brain barrier
New brain-shuttle biologics are overcoming the blood-brain barrier to deliver critical treatments for Alzheimer's and cancer.
📍 The outcome
Denali received FDA approval for a brain-delivery plan to unlock its Alzheimer’s pipeline. Research also focused on utilizing brain-shuttle biologics to cross the blood-brain barrier to treat cancer and other conditions.
Epilogue added 46d ago, after coverage quieted.
Quick answers
What percentage of small-molecule drugs are blocked by the blood-brain barrier?
According to ScienceBlog.com, the blood-brain barrier blocks 98% of small-molecule drugs.
Which company has received FDA approval for its Alzheimer's pipeline?
Tech Times reports that Denali has received FDA approval.
How wide are the tight junctions that filter the blood-brain barrier?
ScienceBlog.com states the junctions are approximately 4 nanometers wide.
The brief
Researchers are developing brain-shuttle biologics to bypass the blood-brain barrier, a filtration system that blocks 98% of small-molecule drugs using junctions approximately 4 nanometers wide. While glucose and ketones cross freely, these new biologics aim to chart paths for medication to enter the brain.
Coverage from Nature and Tech Times highlights Denali's recent FDA approval, which unlocks a pipeline for Alzheimer's treatment. Stock Titan reports that the CEO of Denali is scheduled to open AAIC 2026 with a specific brain-delivery plan.
Future focus includes the application of these delivery methods to treat cancer, as explored by UT MD Anderson. Further details are expected during the upcoming AAIC 2026 presentation.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46d ago.
Who reported it (5)
- What is the blood-brain barrier, and how can we get past it to treat cancer? UT MD Anderson · 50d ago
- Denali CEO to open AAIC 2026 with brain-delivery plan for Alzheimer’s Stock Titan · 50d ago
- Blood-Brain Barrier Crossed: Denali’s FDA Approval Unlocks Alzheimer’s Pipeline Tech Times · 50d ago
- The blood-brain barrier lets glucose and ketones cross freely, but blocks 98% of small-molecule drugs — and the tight junctions doing the filtering are only about 4 nanometers wide ScienceBlog.com · 50d ago
- Brain-shuttle biologics chart new paths across the blood–brain barrier Nature · 50d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
From around our network
Related trends
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
A breakthrough blood test promises earlier Alzheimer’s diagnosis, yet patients grapple with rising confusion and distress.
UK doctors say breakthrough in Alzheimer’s research may have found way to restore sleep
UK doctors find potential breakthrough in Alzheimer's research linked to sleep restoration
A hidden Alzheimer’s tipping point may decide who gets dementia
Midlife brain remodeling may set a hidden tipping point that determines who later develops Alzheimer’s.
The common concern that can age your brain faster and increase Alzheimer’s risk
New research suggests a link between chronic financial hardship and accelerated brain aging, potentially increasing the risk of Alzheimer's.
There May Be A New Way To Clear Alzheimer's Proteins From The Brain
New research suggests distinct methods, including a copper-based drug and CO2 inhalation, may effectively clear toxic Alzheimer's proteins from the brain.